Tratamiento de los tumores de la estroma gastrointestinal (GIST)

Mazur, 1983, Gastric stromal tumors: reappraisal of histogenesis, Am J Surg Pathol, 7, 507, 10.1097/00000478-198309000-00001 Kindblom, 1998, Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the intersticial cell of Cajal, Am J Pathol, 152, 1259 Miettinen, 1995, Gastrointestinal stromal tumors: value of CD34 antigen in their identification and separation from true leiomyomas and schawannomas, Am J Surg Pathol, 19, 207, 10.1097/00000478-199502000-00009 Sircar, 1999, Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors, Am J Surg Pathol, 23, 377, 10.1097/00000478-199904000-00002 Robinson, 2000, Gastrointestinal stromal tumors may originate from a subset of CD34-positive intersticial cells of Cajal, Am J Pathol, 156, 1157, 10.1016/S0002-9440(10)64984-X Poveda, 2005, Guía de práctica clínica en los tumores estromales gastrointestinales, Cir Esp, 78, 1, 10.1016/S0009-739X(05)74635-2 Miettinen, 2001, Gastrointestinal stromal tumors. Definition, clinical, histological, inmunohistochemical, and molecular genetic features and differential diagnosis, Virchows Arch, 438, 1, 10.1007/s004280000338 Miettinen, 2002, Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs); a review, Eur J Cancer, 38, S39, 10.1016/S0959-8049(02)80602-5 Rossi, 2003, Gastrointestinal stromal tumors: from a surgical to a molecular approach, Int J Cancer, 107, 171, 10.1002/ijc.11374 Bucher, 2004, Management of gastrointestinal stromal tumours: from diagnosis to treatment, Swiss Med Wkly, 134, 145 Heinrich, 2002, Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations, Hum Pathol, 33, 484, 10.1053/hupa.2002.124124 Asman, 1999, The biology of stem cell factor and its receptor c-kit, Int J Biochem Cell Biol, 31, 1037, 10.1016/S1357-2725(99)00076-X Broudy, 1997, Stem cell factor and hemotopoiesis, Blood, 90, 1345, 10.1182/blood.V90.4.1345 Tsuura, 1994, Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma, and seminoma/dysgerminoma in human: inmunohistochemical study of formalín-fixed, paraffin-embedded tissues, Virchows Arch, 424, 135, 10.1007/BF00193492 Sanders, 1996, A case for interstitial cells of Cajal as pacemekers and mediators of neurotransmission in the gastrointestinal tract, Gastroenterology, 111, 492, 10.1053/gast.1996.v111.pm8690216 Hirota, 1998, Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors, Science, 279, 577, 10.1126/science.279.5350.577 Rubin, 2001, KIT activation is a ubiquitous feature of gastrointestinal stromal tumors, Cancer Res, 61, 8118 Lasota, 1999, Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas, Am J Pathol, 154, 53, 10.1016/S0002-9440(10)65250-9 Corless, 2004, Biology of gastrointestinal tumors, J Clin Oncol, 22, 3813, 10.1200/JCO.2004.05.140 Heinrich, 2003, PDGFRA activating mutations in gastrointestinal stromal tumors, Science, 299, 708, 10.1126/science.1079666 Miettinen, 2000, Inmunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT), Mod Pathol, 13, 1134, 10.1038/modpathol.3880210 Wang, 2000, Cellular origin of gastrointestinal stromal tumors: A study of 27 cases, Arch Pathol Lab Med, 124, 1471 Graadt van Roggen, 2001, The histopathological differential diagnosis, J Clin Pathol, 54, 96, 10.1136/jcp.54.2.96 Miettinen, 1998, Gastrointestinal stromal tumours, Ann Chir Gynaecol, 87, 278 Miettinen, 1999, Gastrointestinal stromal tumours: recent advances in understanding of their biology, Hum Pathol, 30, 1213, 10.1016/S0046-8177(99)90040-0 Ludwig, 1997, Gut stromal tumours and their clinical behavior, Am J Surg, 173, 390, 10.1016/S0002-9610(97)00064-0 Shiu, 1982, Myosarcomas of the stomach: natural history, prognostic factors and management, Cancer, 49, 177, 10.1002/1097-0142(19820101)49:1<177::AID-CNCR2820490136>3.0.CO;2-K Davis, 2000, Tumors of the stomach, World J Surg, 24, 412, 10.1007/s002689910066 Ruiz, 2000, Multiple malignant gastric stromal tumors presenting with GI bleeding: a case report and a review of the literature, Gastrointest Endosc, 51, 225, 10.1016/S0016-5107(00)70427-5 Akwari, 1978, Leiomyosarcoma of the small and large bowel, Cancer, 42, 1375, 10.1002/1097-0142(197809)42:3<1375::AID-CNCR2820420348>3.0.CO;2-4 Blanchard, 2000, Tumors of the smal intestine, World J Surg, 24, 421, 10.1007/s002689910067 Miettinen, 2000, Gastrointestinal stromal tumors and leiomyosarcomas in the colon. A clinicopathologic, inmunohistochemical and molecular genetic study of 44 cases, Am J Surg Pathol, 24, 1339, 10.1097/00000478-200010000-00003 Miettinen, 2000, Esophageal stromal tumors: a clinicopathologic, inmunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas, Am J Surg Pathol, 24, 211, 10.1097/00000478-200002000-00007 Hatch, 2000, Tumors of the esophagus, World J Surg, 24, 401, 10.1007/s002689910065 Miettinen, 1999, Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases, Am J Surg Pathol, 23, 1109, 10.1097/00000478-199909000-00015 Lin, 2003, Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors, Worl J Gastroenterol, 9, 2809, 10.3748/wjg.v9.i12.2809 Fletcher, 2002, Diagnosis of gastrointestinal stromal tumors: a consensus approach, Hum Pathol, 33, 459, 10.1053/hupa.2002.123545 Hirota, 2003, Gain-of function mutations of platelet-derives growth factor receptor alpha gene in gastrointestinal stromal tumors, Gastroenterology, 125, 660, 10.1016/S0016-5085(03)01046-1 Rubin, 2000, Molecular insights into the histogenesis and pathogenesis of gastrointestinal stromal tumors, Int J Surg Pathol, 8, 5, 10.1177/106689690000800105 Blay, 2004, Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias, Clin Cancer Res, 10, 4089, 10.1158/1078-0432.CCR-04-0630 Duensing, 2004, Protein kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs), Cancer Res, 64, 5127, 10.1158/0008-5472.CAN-04-0559 Tsujimura, 2001, Expression of the inmediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal, Am J Pathol, 158, 817, 10.1016/S0002-9440(10)64029-1 West, 2004, The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status, Am J Pathol, 165, 107, 10.1016/S0002-9440(10)63279-8 Shidham, 2002, Inmonohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor, Arch Pathol Lab Med, 126, 1189 Pylkkanen, 2003, Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors, Hum Pathol, 34, 872, 10.1016/S0046-8177(03)00349-6 Medeiros, 2004, KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications, Am J Surg Pathol, 28, 889, 10.1097/00000478-200407000-00007 Roberts, 2002, Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease, Eur J Cancer, 38, S37, 10.1016/S0959-8049(02)80601-3 Saund, 2004, Gastrointestinal stromal tumors (GISTs), Curr Opin Gastroenterol, 20, 89, 10.1097/00001574-200403000-00007 Lau, 2004, Imaging of gastrointestinal stromal tumors (GIST), Clin Radiol, 59, 487, 10.1016/j.crad.2003.10.018 Chak, 1997, Endosonographic differentiation of benign and malignant stromal cell tumors, Gastrointest Endosc, 45, 468, 10.1016/S0016-5107(97)70175-5 Hunt, 2003, Yield of tissue sampling for submucosal lesions evaluated by endoscopic ultrasound, Gastrointest Endosc, 57, 68, 10.1067/mge.2003.34 Waxman, 2002, High-frequency probe EUS-assisted endoscopic mucosal resection: a therapeutic strategy for submucosal tumors of the GI tract, Gastrointest Endosc, 55, 44, 10.1067/mge.2002.119871 Davila, 2003, Gastrointestinal stromal tumors, Gastrointest Endosc, 58, 80, 10.1067/mge.2003.317 Caletti, 1989, Endoscopic ultrasonography in the diagnosis of gastric submucosal tumor, Gastrointest Endosc, 35, 413, 10.1016/S0016-5107(89)72846-7 Boyce, 1991, Evaluation of submucosal upper gastrointestinal tract lesions by endoscopic ultrasound, Gastrointest Endosc, 37, 449, 10.1016/S0016-5107(91)70778-5 Tio, 1990, Endoscopic ultrasonography for the evaluation of smooth muscle tumors in the upper gastrointestinal tract: an experience with 42 cases, Gastrointest Endosc, 36, 342, 10.1016/S0016-5107(90)71061-9 Kameyama, 1997, Endoscopic ultrasonography in the diagnosis of submucosal lesions of the large intestine, Gastrointest Endosc, 46, 406, 10.1016/S0016-5107(97)70032-4 Gu, 2001, Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cytomorphologic and inmunohistochemical study of 12 cases, Diagn Cytopathol, 25, 343, 10.1002/dc.10003 Rader, 2001, Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, inmunocytochemistry, and mutational analysis of c-kit, Cancer Cytopathol, 93, 269, 10.1002/cncr.9041 Ando, 2002, The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with inmunohistochemical analysis, Gastrointest Endosc, 55, 37, 10.1067/mge.2002.120323 Demetri, 2004, Optimal management of patients with gastrointestinal stromal tumors (GIST). Expansion and update of NCCN Clinical Practice Guidelines, JNCCN, 2, 1 Hasegawa, 1998, Gastric stromal sarcomas correlation of MR imaging and histopatologic findings in nine patients, Radiology, 208, 591, 10.1148/radiology.208.3.9722833 Choi, 2004, CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings, AJR Am J Roentgenol, 183, 1619, 10.2214/ajr.183.6.01831619 Gayed, 2004, The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors, J Nucl Med, 45, 17 Kristensen, 2003, FDG-PET versus spiral CT for evaluation of STI-571 treatment of gastrointestinal stromal tumors [resumen 3311], ASCO Benjamin, 2003, We should desist using RECIST, at least in GIST [resumen 195] Demetri, 2002, Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors, N Engl J Med, 22, 472, 10.1056/NEJMoa020461 Blay, 2005, Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST consensus conference of March 20-21st 2004, under the auspices of ESMO, Ann Oncol, 16, 566, 10.1093/annonc/mdi127 Joensuu, 2002, Management of malignant gastrointestinal stromal tumors, Lancet Oncol, 3, 655, 10.1016/S1470-2045(02)00899-9 Van den Abbeele, 2002, Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs), Eur J Cancer, 38, 60, 10.1016/S0959-8049(02)80604-9 Miettinen, 2005, Gastrointestinal stromal tumors of the stomach. A clinicopathologic, inmunohistochemical, and molecular genetic study of 1765 cases with lng-term follow up, Am J Surg Pathol, 29, 52, 10.1097/01.pas.0000146010.92933.de Bucher, 2004, Are there any prognostic factors for small intestinal stromal tumors?, Am J Surg, 187, 761, 10.1016/j.amjsurg.2003.09.010 Joensuu, 2001, Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor, N Engl J Med, 344, 1052, 10.1056/NEJM200104053441404 Kindblom, 2002, Incidence, prevalence, phenotype and biologic spectrum of gastrointestinal stromal cell tumors (GIST)-a population-based study of 600 cases, Ann Oncol, 13, 157 Noguchi, 2002, Biological analysis of gastrointestinal stromal tumors, Oncol Rep, 9, 1277 Singer, 2002, Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors, J Clin Oncol, 20, 3898, 10.1200/JCO.2002.03.095 Taniguchi, 1999, Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors, Cancer Res, 59, 4297 Wardelmann, 2003, Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors, Int J Cancer, 106, 887, 10.1002/ijc.11323 Chen, 2002, Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GIST) treated with Gleevec (imatinib mesylate), AJR Am J Roentgenol, 179, 1059, 10.2214/ajr.179.4.1791059 Carson, 1994, Results of an aggressive treatment of gastric sarcoma, Ann Surg Oncol, 1, 244, 10.1007/BF02303530 Roberts, 2002, Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease, Eur J Cancer, 38, 537 Blanke, 2001, Gastrointestinal stromal tumors, Current Treat Options Oncol, 6, 1 Crosby, 2001, Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database, Ann Surg Oncol, 8, 50, 10.1007/s10434-001-0050-4 Langer, 2003, Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours, Br J Surg, 90, 332, 10.1002/bjs.4046 Besana-Ciani, 2003, Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST), Scand J Surg, 92, 195, 10.1177/145749690309200304 Miettinen, 2002, Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review, Hum Pathol, 33, 478, 10.1053/hupa.2002.124123 Rossi, 2003, Gastrointestinal stromal tumors: from a surgical to a molecular approach, Int J Cancer, 107, 171, 10.1002/ijc.11374 Demetri, 2002, Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with selective inhibitor mesylate (STI571), Eur J Cancer, 38, 52, 10.1016/S0959-8049(02)80603-7 DeMatteo, 2000, Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival, Ann Surg, 231, 51, 10.1097/00000658-200001000-00008 Van Oosterom, 2001, Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study, Lancet, 358, 1421, 10.1016/S0140-6736(01)06535-7 Van Oosterom, 2002, Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group, Eur J Cancer, 38, 83, 10.1016/S0959-8049(02)80608-6 Benjamin, 2003, Phase III dose-randomized study of imatinib mesylate (STI571) for GIST: intergroup S0033 early results, Proc Ann Meet Am Assoc Clin Oncol, 22, A3271 Verweij, 2004, Progression-free survival in gastrointestinal stromal tumors with high-dose imatinib: randomised trial, Lancet, 364, 1127, 10.1016/S0140-6736(04)17098-0 Rankin, 2004, Dose effect of imatinib in patients with metastasic GIST.Phase III Sarcoma Group Study 50033. [resumen 2005], Proc Ann Meet Am Soc Clin Oncol, 22, A9005, 10.1200/jco.2004.22.14_suppl.9005 Blay, 2004, Continuous vs intermittent imatinib treatment in advanced GIST after one year: a prospective randomized phase III trial of the French Sarcoma Group, Proc Ann Meet Am Soc Clin Oncol, 23, 815 Judson, 2005, Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group, Cancer Chemother Pharmacol, 55, 379, 10.1007/s00280-004-0876-0 Debiec-Rychter, 2004, Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointtestinal stromal tumors entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group, Eur J Cancer, 40, 689, 10.1016/j.ejca.2003.11.025 Tamborini, 2004, A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient, Gastroenterology, 127, 294, 10.1053/j.gastro.2004.02.021 Debiec-Rychter, 2005, Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants, Gastroenterology, 128, 270, 10.1053/j.gastro.2004.11.020 Demetri, 2005, Phase 3, multicenter, randomized, double-blind, placebocontrolled trial of SU11248 in patients following failure of imatinib for metastatic GIST [resumen 4000], J Clin Oncol, 23, 308S, 10.1200/jco.2005.23.16_suppl.4000 Benjamin, 2006, Management of gastrointestinal stromal tumors in the imatinib era: selected case studies, Oncologist, 11, 9, 10.1634/theoncologist.11-1-9